{"id":65594,"date":"2025-03-13T00:02:16","date_gmt":"2025-03-13T00:02:16","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2025\/03\/13\/beautyhealth-reports-full-year-and-fourth-quarter-2024-financial-results\/"},"modified":"2025-03-13T00:02:16","modified_gmt":"2025-03-13T00:02:16","slug":"beautyhealth-reports-full-year-and-fourth-quarter-2024-financial-results","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/beautyhealth-reports-full-year-and-fourth-quarter-2024-financial-results\/","title":{"rendered":"BeautyHealth Reports Full Year and Fourth Quarter 2024 Financial Results"},"content":{"rendered":"
\n

Delivers fourth quarter and full year net sales of $83.5 million and $334.3 million<\/em><\/p>\n

LONG BEACH, Calif., March 12, 2025 (GLOBE NEWSWIRE) — The Beauty Health Company (NASDAQ: SKIN) (\u201cBeautyHealth\u201d), home to flagship brand Hydrafacial, today announced financial results for the fourth quarter ended December\u00a031, 2024 (\u201cQ4 2024\u201d).<\/p>\n

\u201cIn Q4 2024, we continued to strengthen our financial position, exceeding the high end of our guidance for both net sales and adjusted EBITDA,\u201d said CEO Marla Beck. \u201cWe increased consumable sales, expanded our gross margins and continued to reduce our operating expenses, delivering $9 million of adjusted EBITDA in the quarter. We now have over 34,000 global delivery systems serving our large provider base.\u201d<\/p>\n

\u201cIn 2025, we are focused on deepening partnerships, accelerating science-backed innovations, including new product offerings, and enhancing our commercial execution. Despite near-term global macroeconomic uncertainty and industry headwinds, Hydrafacial remains a leading global brand, and we are confident in our ability to execute on our strategy and drive long-term shareholder value.\u201d<\/p>\n

Key Operational and Business Metrics<\/strong><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\u00a0<\/td>\nThree Months Ended December 31,<\/strong><\/td>\n\u00a0<\/td>\nYear Ended December 31,<\/strong><\/td>\n<\/tr>\n
Unaudited ($ in millions)<\/strong> (1)<\/strong><\/sup><\/td>\n\u00a0<\/td>\n2024<\/strong><\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n2023<\/strong><\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n2024<\/strong><\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n2023<\/strong><\/td>\n\u00a0<\/td>\n<\/tr>\n
Delivery Systems net sales<\/td>\n$<\/td>\n26.8<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n$<\/td>\n44.6<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n$<\/td>\n125.4<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n$<\/td>\n206.6<\/td>\n\u00a0<\/td>\n<\/tr>\n
Consumables net sales<\/td>\n\u00a0<\/td>\n56.7<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n52.2<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n208.9<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n191.4<\/td>\n\u00a0<\/td>\n<\/tr>\n
Total net sales<\/td>\n$<\/td>\n83.5<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n$<\/td>\n96.8<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n$<\/td>\n334.3<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n$<\/td>\n398.0<\/td>\n\u00a0<\/td>\n<\/tr>\n
Gross profit<\/td>\n$<\/td>\n52.3<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n$<\/td>\n45.7<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n$<\/td>\n182.3<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n$<\/td>\n155.1<\/td>\n\u00a0<\/td>\n<\/tr>\n
Gross margin<\/td>\n\u00a0<\/td>\n62.7<\/td>\n%<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n47.2<\/td>\n%<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n54.5<\/td>\n%<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n39.0<\/td>\n%<\/td>\n<\/tr>\n
Adjusted gross profit(2)<\/sup><\/td>\n$<\/td>\n56.0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n$<\/td>\n52.8<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n$<\/td>\n207.2<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n$<\/td>\n249.8<\/td>\n\u00a0<\/td>\n<\/tr>\n
Adjusted gross margin(2)<\/sup><\/td>\n\u00a0<\/td>\n67.1<\/td>\n%<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n54.6<\/td>\n%<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n62.0<\/td>\n%<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n62.8<\/td>\n%<\/td>\n<\/tr>\n
Net loss<\/td>\n$<\/td>\n(10.3<\/td>\n)<\/td>\n\u00a0<\/td>\n$<\/td>\n(9.4<\/td>\n)<\/td>\n\u00a0<\/td>\n$<\/td>\n(29.1<\/td>\n)<\/td>\n\u00a0<\/td>\n$<\/td>\n(100.1<\/td>\n)<\/td>\n<\/tr>\n
Adjusted EBITDA(2)<\/sup><\/td>\n$<\/td>\n9.0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n$<\/td>\n3.4<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n$<\/td>\n12.3<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n$<\/td>\n24.3<\/td>\n\u00a0<\/td>\n<\/tr>\n
Adjusted EBITDA margin(2)<\/sup><\/td>\n\u00a0<\/td>\n10.8<\/td>\n%<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n3.5<\/td>\n%<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n3.7<\/td>\n%<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n6.1<\/td>\n%<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n<\/table>\n

<\/p>\n\n\n\n\n\n
\u00a0<\/td>\nThree Months Ended December 31,<\/strong><\/td>\n\u00a0<\/td>\nYear Ended December 31,<\/strong><\/td>\n<\/tr>\n
Unaudited<\/strong><\/td>\n2024<\/strong><\/td>\n\u00a0<\/td>\n2023<\/strong><\/td>\n\u00a0<\/td>\n2024<\/strong><\/td>\n\u00a0<\/td>\n2023<\/strong><\/td>\n<\/tr>\n
Total delivery systems sold<\/td>\n1,087<\/td>\n\u00a0<\/td>\n1,551<\/td>\n\u00a0<\/td>\n4,907<\/td>\n\u00a0<\/td>\n8,287<\/td>\n<\/tr>\n
Active install base(3)<\/sup><\/td>\n34,735<\/td>\n\u00a0<\/td>\n31,446<\/td>\n\u00a0<\/td>\n34,735<\/td>\n\u00a0<\/td>\n31,446<\/td>\n<\/tr>\n<\/table>\n

__________________________<\/p>\n\n\n\n\n\n
(1)<\/td>\nAmounts may not sum due to rounding.<\/td>\n<\/tr>\n
(2)<\/td>\nSee “Non-GAAP Financial Measures” below.<\/td>\n<\/tr>\n
(3)<\/td>\nEstimated number of delivery systems owned by providers that have purchased consumables in the trailing twelve-month period.<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n<\/table>\n

BeautyHealth completed the year with an estimated active install base of 34,735 units, as compared to 31,446 in the prior year, resulting in growth in consumable net sales. The decrease in overall revenue resulted from fewer units placed year over year, impacted by a challenging macroeconomic environment and the prior year international launch of the Syndeo Delivery System (“Syndeo”). The Company continues to evaluate its strategic footprint, exiting its third-party manufacturing arrangement in 2024, and is expected to convert its China market from a direct sales to distributor model in 2025.<\/p>\n

Fourth Quarter Financial Highlights<\/strong><\/p>\n